Kazuhiko Kondo

This inventor holds 21 USPTO granted patents, primarily in Azetidinone Compounds. Top assignees: Tanabe Seiyaku Company, Limited, Mitsubishi Tanabe Pharma Corporation. Active years: 1976-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuhiko Kondo. Retrieved from https://idiyas.com/inventor/kazuhiko-kondo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21

% Patents Active = 95.2

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 122(Granted Patents)

Location History:

Osaka, JA (1976)
Osaka, JP (1992 - 2008)

Company Filing History:

20 out of 324

Tanabe Seiyaku Company, Limited

patents

1 out of 263

Mitsubishi Tanabe Pharma Corporation

patents

Years Active: 1976-2008

Loading Chart...

Areas of Expertise:

Azetidinone Compounds

Carbapenem Derivatives

Naphthalene Derivatives

Beta-Lactam Derivative

Optically Active Compounds

Heterocyclic Alkanamide

Biphenyl Derivatives

Mercaptan Compounds

Synthetic Intermediates

Alkylation Process

Protecting Group Removal

Novel Processes

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7439368 - Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative (2008-10-21),

2. 6011150 - Azetidinone compound and process for preparation thereof (2000-01-04),

3. 5847115 - Azetidinone compound and process for preparation thereof (1998-12-08),

4. 5703234 - Heterocyclic alkanamide (1997-12-30),

5. 5631363 - Azetidinone compound and process for preparation thereof (1997-05-20),

6. 5589592 - Process for preparing .beta.-lactam derivative and synthetic intermediate (1996-12-31),

7. 5587474 - Method for removing the protecting group for carboxyl group (1996-12-24),

8. 5550229 - Alkylation process for preparing azetidinone compound and starting (1996-08-27),

9. 5495012 - Process for preparing optically active 4-mercapto-2-pyrrolidone (1996-02-27),

10. 5442055 - Azetidinone compound and process for preparation thereof (1995-08-15),

11. 5424446 - Process for preparing optically active 4-mercapto-2-pyrrolidone (1995-06-13),

12. 5414081 - Process for preparing .beta.-lactam derivative and synthetic (1995-05-09),

13. 5359059 - Process for preparing carbapenem derivatives (1994-10-25),

14. 5342941 - Naphthalene derivatives, processes for preparing the same, and synthetic (1994-08-30),

15. 5260438 - Method for removing the protecting group for hydroxy group (1993-11-09),

Title: Kazuhiko Kondo: A Noteworthy Innovator in Pharmaceutical Patents

Introduction

Kazuhiko Kondo, located in Osaka, Japan, is a prominent inventor recognized for his significant contributions to pharmaceutical innovations. With a total of 21 patents to his name, Kondo has established himself as a key figure in the development of compounds that play crucial roles in medical applications.

Latest Patents

Among his latest patents are the "Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative" and the "Azetidinone compound and process for preparation thereof." The first patent details a method for preparing a compound that serves as an inhibitor of activated blood coagulation factor X, which is vital for managing blood-clotting disorders. The azetidinone compound patent provides a synthetic intermediate for creating the 1.beta.-methylcarbapenem-type antibacterial agent, showcasing Kondo's innovative approach in the pharmaceutical sector.

Career Highlights

Kondo's career includes significant roles at reputed organizations such as Tanabe Seiyaku Company, Limited, and Tanabe Seiyaku Co., Ltd. His work at these companies has enabled him to focus on research and development in pharmaceuticals, resulting in a robust portfolio of patents that highlight his expertise and dedication to innovation in the field.

Collaborations

Throughout his career, Kazuhiko Kondo has collaborated with esteemed individuals such as Tameo Iwasaki and Hiroshi Horikawa. These collaborations have contributed to the successful development and patenting of various pharmaceutical compounds, enhancing the scientific community's understanding of novel treatment options.

Conclusion

Kazuhiko Kondo's extensive portfolio of patents and collaborative efforts in the pharmaceutical industry underscore his dedication to innovation. His work continues to influence the development of critical medical compounds, marking him as a key inventor in the field. As the demand for effective healthcare solutions grows, Kondo's contributions remain vital in shaping the future of pharmaceuticals.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]